SK Biopharm, First Korean Pharmaceutical Company to Win CES 2023 Innovation Award

In-House Developed Wearable Devices
Introducing Zero Glass and Zero Wired
Achievement in Digital Health Awards

SK Biopharm's wearable devices 'Zero Glass' (left) and 'Zero Wired' [Photo by SK Biopharm]

[Asia Economy Reporter Lee Gwan-joo] SK Biopharm announced on the 17th that its self-developed wearable devices, 'Zero Glasses' and 'Zero Wired,' have won the CES 2023 Innovation Awards.

CES 2023, the world's largest IT technology exhibition, is scheduled to be held in Las Vegas, USA, from January 5 to 8 next year (local time), and the Innovation Award recipients were announced ahead of the event. SK Biopharm achieved the remarkable feat of being the first domestic pharmaceutical company to receive a CES Innovation Award in the digital health category, recognized for its outstanding design and differentiated technology. The CES Innovation Award is given by the Consumer Technology Association (CTA), the organizer of CES, to products and new technologies that demonstrate technological excellence, aesthetics, and innovation.

Zero Glasses feature a glasses design suitable for everyday use, while Zero Wired is a wired device connected to a smartphone. Both can measure complex biosignals such as brain waves, electrocardiograms, and movement. Both products allow real-time biosignal recording and transmission through SK Biopharm's self-developed mobile application, 'Zero App,' enabling easy use not only by medical professionals but also by individual patients. In particular, Zero Wired and the Zero App are planned to be developed as medical devices for epilepsy seizure detection and prediction through clinical validation.

SK Biopharm included the word 'Zero' commonly in the names of its wearable devices and mobile apps. 'Zero' is SK Biopharm's development project for epilepsy seizure detection and prediction. It reflects SK Biopharm's social value realization and vision to achieve 'Zero Seizure' through the innovative epilepsy drug cenobamate.

An SK Biopharm official explained, "We plan to participate in CES 2023 to showcase the devices and provide opportunities for visitors to experience live demonstrations on-site."